"I cannot fathom why it has held $1 other than pure speculation.."
There is a more positive viewpoint. Isn't it possible that another company (Pharming?) or large institutional investor is accumulating at these prices, anticipating eventual EMEA approval or acquisition of the shares of GTCB it hasn't acquired?